Search research articles
Contact Us
Filters
Showing results (41-50 of 193) with videos related to
Page
of 20
Sort By:
Journal of Viral Hepatitis
|
September 9, 2025
Clinical Impact of Continuation Versus Cessation of Antiviral Therapy in Chronic Hepatitis B: A Modelling Study With Implications for Hepatitis B Cure
Amir M Mohareb, Ghideon Ezaz, Arthur Y Kim, et al.
The New England Journal of Medicine
|
December 8, 2022
Case 37-2022: A 55-Year-Old Man with Fatigue, Weight Loss, and Pulmonary Nodules
Matthew B Roberts, Jarone Lee, Mark C Murphy, et al.
Hepatology (Baltimore, Md.)
|
July 18, 2017
Comments on cochrane review on direct-acting antivirals for hepatitis C
Anna S Lok, Raymond T Chung, Hugo E Vargas, et al.
The Journal of Rheumatology
|
August 2, 2021
Screening for Hepatitis B Virus Prior to Initiating Tocilizumab and Tofacitinib in Patients With Rheumatic Diseases: A Cross-sectional Study
Amir M Mohareb, Naomi J Patel, Xiaoqing Fu, et al.
The New England Journal of Medicine
|
July 8, 2026
Case 19-2026: A 68-Year-Old Man with Fatigue, Fever, and Hypoxemia
Hilary J Goldberg, Harikrishnan Nandakumar, Brian C Keller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
IDSA/AASLD Response to Cochrane Review on Direct-Acting Antivirals for Hepatitis C
William G Powderly, Susanna Naggie, Arthur Y Kim, et al.
Annals of Internal Medicine
|
October 20, 2017
Benefits of Direct-Acting Antivirals for Hepatitis C
Anna S Lok, Raymond T Chung, Hugo E Vargas, et al.
Hepatology (Baltimore, Md.)
|
April 10, 2014
Genetics of spontaneous clearance of hepatitis C virus infection: a complex topic with much to learn
Jason Grebely, Gregory J Dore, Arthur Y Kim, et al.
Hepatology (Baltimore, Md.)
|
November 1, 2012
A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users
Arthur Y Kim, Ellen H Nagami, Christopher E Birch, et al.
Open Forum Infectious Diseases
|
November 28, 2022
Bebtelovimab for High-Risk Outpatients With Early COVID-19 in a Large US Health System
Scott Dryden-Peterson, Andy Kim, Mary-Ruth Joyce, et al.
Page
of 20
Search research articles
Search
Showing results (41-50 of 193) with videos related to
Sort By:
Page
of 20
Journal of Viral Hepatitis
|
September 9, 2025
Clinical Impact of Continuation Versus Cessation of Antiviral Therapy in Chronic Hepatitis B: A Modelling Study With Implications for Hepatitis B Cure
Amir M Mohareb, Ghideon Ezaz, Arthur Y Kim, et al.
The New England Journal of Medicine
|
December 8, 2022
Case 37-2022: A 55-Year-Old Man with Fatigue, Weight Loss, and Pulmonary Nodules
Matthew B Roberts, Jarone Lee, Mark C Murphy, et al.
Hepatology (Baltimore, Md.)
|
July 18, 2017
Comments on cochrane review on direct-acting antivirals for hepatitis C
Anna S Lok, Raymond T Chung, Hugo E Vargas, et al.
The Journal of Rheumatology
|
August 2, 2021
Screening for Hepatitis B Virus Prior to Initiating Tocilizumab and Tofacitinib in Patients With Rheumatic Diseases: A Cross-sectional Study
Amir M Mohareb, Naomi J Patel, Xiaoqing Fu, et al.
The New England Journal of Medicine
|
July 8, 2026
Case 19-2026: A 68-Year-Old Man with Fatigue, Fever, and Hypoxemia
Hilary J Goldberg, Harikrishnan Nandakumar, Brian C Keller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
IDSA/AASLD Response to Cochrane Review on Direct-Acting Antivirals for Hepatitis C
William G Powderly, Susanna Naggie, Arthur Y Kim, et al.
Annals of Internal Medicine
|
October 20, 2017
Benefits of Direct-Acting Antivirals for Hepatitis C
Anna S Lok, Raymond T Chung, Hugo E Vargas, et al.
Hepatology (Baltimore, Md.)
|
April 10, 2014
Genetics of spontaneous clearance of hepatitis C virus infection: a complex topic with much to learn
Jason Grebely, Gregory J Dore, Arthur Y Kim, et al.
Hepatology (Baltimore, Md.)
|
November 1, 2012
A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users
Arthur Y Kim, Ellen H Nagami, Christopher E Birch, et al.
Open Forum Infectious Diseases
|
November 28, 2022
Bebtelovimab for High-Risk Outpatients With Early COVID-19 in a Large US Health System
Scott Dryden-Peterson, Andy Kim, Mary-Ruth Joyce, et al.
Page
of 20